Antibiotic-Associated Adverse Events in Hospitalized Children

Abstract

Background Antibiotic-associated adverse events (AEs) in hospitalized children have not been comprehensively characterized. Methods We conducted a retrospective observational study of children hospitalized at The Johns Hopkins Hospital receiving ≥24 hours of systemic antibiotics. Consensus regarding antibiotic-associated AE definitions was established by 5 infectious diseases specialists prior to data collection. Two physicians reviewed potential AEs and determined whether they were more likely than not related to antibiotics after comprehensive manual chart review. Inpatient and post-discharge AEs were identified using the Epic Care Everywhere network. AEs evaluated from the initiation of antibiotics until 30 days after antibiotic completion included gastrointestinal, hematologic, hepatobiliary, renal, neurologic, dermatologic, cardiac, myositis, vascular access device-related events, and systemic reactions. Ninety-day AEs included Clostridioides difficile infections, multidrug-resistant organism infections, and clinically significant candidal infections. The impact of AEs was categorized as necessitating additional diagnostic testing, changes in medications, unplanned medical encounters, prolonged or new hospitalizations, or death. Results Among 400 antibiotic courses, 21% were complicated by at least one AE and 30% occurred post-discharge. Each additional day of antibiotics was associated with a 7% increased odds of an AE. Of courses complicated by an AE, 66% required further intervention. Hematologic, gastrointestinal, and renal AEs were the most common, accounting for 31%, 15%, and 11% of AEs, respectively. AEs complicated 35%, 35%, 19%, and 18% of courses of piperacillin-tazobactam, tobramycin, ceftazidime, and vancomycin, respectively. Conclusions More than 1 in 5 courses of antibiotics administered to hospitalized children are complicated by AEs. Clinicians should weigh the risk of harm against expected benefit when prescribing antibiotics.

Culture Ordering for Patients with New-onset Fever: A Survey of Pediatric Intensive Care Unit Clinician Practices

“… 1 In future clinical decision-support tool iterations, we plan to evaluate other patient-level outcomes, such as adverse outcomes from antibiotic use, central line complications, length of stay, mortality, and readmission rates. We recognize that one-fifth of pediatric patients have adverse outcomes from antibiotic administration, 24 such as acute kidney injury or Clostridium difficile infections, and hypothesize that any reduction in culture ordering practice and subsequent antibiotic administration will improve patient care. With the integration of neonatal sepsis, fever and neutropenia, and meningitis into our future clinical decision-support tool, we also hypothesize earlier identification and treatment of these conditions with improved length of stay and functional outcomes.…”

Defining effective durations of antibiotic therapy for community-acquired pneumonia and urinary tract infections in hospitalized children

“…Much of the published literature regarding the consequences of antibiotic overuse and misuse is in the adult population. However, Same et al [21] found that among hospitalized children receiving at least 24 h of systemic antibiotic therapy, 21% of antibiotic courses were complicated by at least one adverse events. Furthermore, each additional day of antibiotic therapy in a hospitalized child was associated with a 7% increased odds of developing an adverse event.…”

Optimizing Nanopore Sequencing for Rapid Detection of Microbial Species and Antimicrobial Resistance in Patients at Risk of Surgical Site Infections

“…This would reduce the number of surgical patients exposed to broad-spectrum antimicrobial therapy and contribute to antibiotic stewardship. Early de-escalation of postoperative antimicrobial therapy could also reduce the risk of antibiotic-associated adverse events ( 21 , 49 , 50 ) and the health care costs associated with administration of antibiotics ( 51 ).…”